ESPR

#2333
Esperion Therapeutics, Inc.
3.35
+1.82%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
3.35
3.35
Intervallo Annuale
0.69
4.18
Variazione giornaliera
+1.82%
Variazione Mensile
-2.05%
Variazione di 6 mesi
+52.97%
Variazione Annuale
+98.22%
Chiusura Precedente
3.29
Open
3.35
Bid
Ask
Low
3.35
High
3.35
Volume
69
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024

Esperion Therapeutics Inc

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Notizie